{"url":"https://lda.senate.gov/api/v1/filings/d9bb2d41-27de-4a20-97b4-e88caa664762/","filing_uuid":"d9bb2d41-27de-4a20-97b4-e88caa664762","filing_type":"Q4","filing_type_display":"4th Quarter - Report","filing_year":2018,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/d9bb2d41-27de-4a20-97b4-e88caa664762/print/","filing_document_content_type":"text/html","income":"70000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Jerome Filip","dt_posted":"2019-01-21T15:04:18.060000-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1341 G Street NW, 6th Floor","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":65191,"url":"https://lda.senate.gov/api/v1/registrants/65191/","house_registrant_id":35579,"name":"VENN STRATEGIES","description":"A political and public affairs consulting firm.","address_1":"750 9th St NW, Suite 650","address_2":null,"address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JAY ENGLESON","contact_telephone":"+1 301-509-9933","dt_updated":"2026-07-20T11:43:32.403140-04:00"},"client":{"id":162783,"url":"https://lda.senate.gov/api/v1/clients/162783/","client_id":1003670,"name":"ASSERTIO THERAPEUTICS","general_description":"Pharmaceuticals","client_government_entity":false,"client_self_select":null,"state":"IL","state_display":"Illinois","country":"US","country_display":"United States of America","ppb_state":"IL","ppb_state_display":"Illinois","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2018-09-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Promoting policies that support patient access to therapies.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":25887,"prefix":null,"prefix_display":null,"first_name":"STEPHANIE","nickname":null,"middle_name":null,"last_name":"SILVERMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61934,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"LEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61267,"prefix":null,"prefix_display":null,"first_name":"NATASCHA","nickname":null,"middle_name":null,"last_name":"CUMBERLIDGE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":64833,"prefix":null,"prefix_display":null,"first_name":"MICHELLE","nickname":null,"middle_name":null,"last_name":"SEGER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68900,"prefix":null,"prefix_display":null,"first_name":"AUSTIN","nickname":null,"middle_name":"TYLER","last_name":"ROBERTS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67108,"prefix":null,"prefix_display":null,"first_name":"PETER","nickname":null,"middle_name":null,"last_name":"GOELZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69168,"prefix":null,"prefix_display":null,"first_name":"BRIDGET","nickname":null,"middle_name":null,"last_name":"ANSHUS","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}